Clinical Trial

Impact of Vaccine Funding by the National Health Insurance on Vaccination Coverage Among Patients Targeted by Current Vaccination Recommendations and Followed in Outpatient Consultations

Study acronym: VAXINOVA
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of our study is to evaluate the impact of vaccine funding for patients seen in outpatient consultations within four healthcare institutions in the Ile-de-France region in France, made possible through the establishment of a tripartite agreement between the hospital group, the Île-de-France Regional Health Agency (ARS IDF), and the Primary Health Insurance Fund (CPAM).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-17; most recent amendment 2026-04-02.
Status change: Not Yet Recruiting → Recruiting 2025-12-01
Trial Details
NCT Number NCT07243236
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Collaborators: Agence régionale de santé Ile de France, Institut de Recherche en Santé Publique, France, URC-CIC Paris Descartes Necker Cochin
Conditions Healthcare Providers, Postpartum
Enrollment 2,920 participants
Start Date 2025-11-19
Primary Completion 2027-05 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-04-08